Radioactive Drug Research Committee (RDRC) Program

How Does an RDRC Obtain FDA Approval? [§ 361.1(c)(4)]

Submit an Application

1.      Complete FDA 2914 (Word) including:

• the names and qualifications of the RDRC members and consultants [§ 361.1(c)(4)]

• a statement that the RDRC agrees to comply with the requirements set forth in § 361.1. [§ 361.1(c)(4)]

2.      We recommend that you attached a current curriculum vitae (CV) (dated) for each RDRC member and consultant.  Each CV should include the specific qualifications and experience that meet the requirements of membership (see What are the Qualifications and Requirements of RDRC Membership?)

3.      Submit the completed application form and CVs to the following address:

Food and Drug Administration

Center for Drug Evaluation and Research

Division of Medical Imaging and Radiopharmaceutical Drug Products

(HFD-160)

5600 Fishers Lane, Room 18B-45

Rockville, MD 20857

Attention: RDRC (CAPT Richard Fejka)

Approval by FDA

1.      FDA will review the RDRC application and, if acceptable, issue an approval letter to the RDRC chairperson. 

Approval is based upon a positive assessment of the qualifications of the members of the RDRC and the assurance that all necessary fields of expertise are covered [§ 361.1(c)(4)] (see What are the Qualifications and Requirements of RDRC Membership?).

2.      A RDRC must obtain FDA approval before it may approve research studies under 21 CFR 361.1 [§ 361.1(b)(1)]. 

Approval of a RDRC will remain in effect unless and until FDA withdraws such approval.  Approval of a RDRC may be withdrawn at any time for failure of the RDRC to comply with the requirements of § 361.1 [§ 361.1(c)(4)].

Back to Top     Back to RDRC

Date created: September 20, 2004, updated May 25, 2006

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research